L. Smith

Nessuna posizione attualmente

Patrimonio netto: 11 M $ in data 31/03/2024

57 anni

Health Technology

Consumer Services

Profilo

L.
Mary Smith served as Vice President-Product Development at United Therapeutics Corp.
from 2014 to 2016.
She then worked as Executive Vice President-Gene Therapy at Bamboo Therapeutics, Inc. from 2016 to 2017.
Currently, she is the Chief Development Officer at Springworks Therapeutics, Inc. since 2020.
Dr. Smith received her undergraduate and doctorate degrees from the University of New Hampshire.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
SPRINGWORKS THERAPEUTICS, INC. 0.32%	08/01/2024	233 363 ( 0.32% )	11 M $	31/03/2024

Precedenti posizioni note di L. Smith

Società	Posizione	Fine
SPRINGWORKS THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	15/12/2020
Bamboo Therapeutics, Inc. Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC.	Corporate Officer/Principal	01/08/2017
UNITED THERAPEUTICS CORPORATION	Corporate Officer/Principal	01/06/2016

Vedi nel dettaglio l'esperienza di L. Smith

Formazione di L. Smith

University of New Hampshire

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di L. Smith

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
UNITED THERAPEUTICS CORPORATION	Health Technology
SPRINGWORKS THERAPEUTICS, INC.	Health Technology

Aziende private	1
Bamboo Therapeutics, Inc. Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC.	Health Technology